Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Adv Drug Deliv Rev. 2011 Sep 6;64(2):200–216. doi: 10.1016/j.addr.2011.08.006

Fig. 15.

Fig. 15

(a) Synthesis of peptide modified AuNP mediated by BSA. A desired peptide containing terminal cysteine was conjugated to MBS (3-maleimidobenzoic acid N-hydroxysuccinimide ester) on surface lysine residues of BSA. Adapted with permission from [104]. (b) Peptide sequences used in NP-BSA-Peptide complexes. (c-d) NP-peptide complexes incubated with HepG2 cells for 2 h: peptide 2 (c), peptide 3 (d). Adapted with permission from [105].